DeepMed Research

Institute of Oncology Ljubljana

🇸🇮Slovenia

Country: 🇸🇮Slovenia

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.onko-i.si/

Clinical Trials

Correlation of Fecal Microbiome and Its Metabolites With Outcome of Radiotherapy in Head and Neck Carcinoma

Active, not recruiting

Conditions: Head and Neck Squamous Cell Carcinoma

First Posted Date: 2021-12-14

Last Posted Date: 2024-03-05

Lead Sponsor: Institute of Oncology Ljubljana

Target Recruit Count: 40

Registration Number: NCT05156177

Locations: 🇸🇮
Institute of Oncology Ljubljana, Ljubljana, Slovenia

Intratumoral phIL12 GET

Phase 1

Completed

Conditions: Basal Cell Carcinoma

Interventions: Drug: phIL12 GET

First Posted Date: 2021-10-13

Last Posted Date: 2023-12-14

Lead Sponsor: Institute of Oncology Ljubljana

Target Recruit Count: 9

Registration Number: NCT05077033

Locations: 🇸🇮
University Medical Centre Ljubljana, Department of Otorhinolaryngology and Cervicofacial Surgery, Ljubljana, Slovenia
🇸🇮
Institute of Oncology Ljubljana, Ljubljana, Slovenia

Consolidation Versus Induction Chemotherapy in Total Neoadjuvant Therapy of Rectal Cancer With High Risk for Recurrence

Phase 2

Recruiting

Conditions: Locally Advanced Rectal Cancer

Interventions: Other: consolidation chemotherapy
Other: induction chemotherapy

First Posted Date: 2021-09-23

Last Posted Date: 2021-09-23

Lead Sponsor: Institute of Oncology Ljubljana

Target Recruit Count: 62

Registration Number: NCT05054959

Locations: 🇸🇮
Institute of Oncology, Ljubljana, Slovenia

Electrochemotherapy of Gynecological Cancers

Phase 2

Recruiting

Conditions: Gynecological Cancers

Interventions: Combination Product: Electrochemotherapy with bleomycin or cisplatin

First Posted Date: 2021-02-18

Last Posted Date: 2024-10-17

Lead Sponsor: Institute of Oncology Ljubljana

Target Recruit Count: 30

Registration Number: NCT04760327

Locations: 🇸🇮
Institute of oncology Ljubljna, Ljubljana, Slovenia

Total Neoadjuvant Therapy Versus Standard Therapy of Locally Advanced Rectal Cancer With High Risk Factors for Failure

Completed

Conditions: Rectal Cancer

Interventions: Drug: Capecitabine

First Posted Date: 2020-12-22

Last Posted Date: 2024-10-17

Lead Sponsor: Institute of Oncology Ljubljana

Target Recruit Count: 161

Registration Number: NCT04679597

FDG PET/CT Radiomics Analyses of Lung Cancer Patients Treated With Immunotherapy

Completed

Conditions: Non-small Cell Lung Cancer

First Posted Date: 2019-07-05

Last Posted Date: 2024-10-18

Lead Sponsor: Institute of Oncology Ljubljana

Target Recruit Count: 30

Registration Number: NCT04007068

Locations: 🇸🇮
Institut of oncology Ljubljana, Ljubljana, Slovenia

Individual Approach in Gynecological Cancer Brachytherapy

Not Applicable

Conditions: Cancer

Interventions: Other: 3D printed applicator

First Posted Date: 2018-03-15

Last Posted Date: 2018-03-15

Lead Sponsor: Institute of Oncology Ljubljana

Target Recruit Count: 13

Registration Number: NCT03466957

Locations: 🇸🇮
Institute of Oncology Ljubljana, Ljubljana, Slovenia

Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II

Phase 2

Completed

Conditions: Liver Metastases

Interventions: Procedure: Electrochemotherapy
Device: Cliniporator Vitae®
Drug: Bleomycin PHC 15 e. (United States Pharmacopeia - USP)

First Posted Date: 2015-02-02

Last Posted Date: 2021-03-24

Lead Sponsor: Institute of Oncology Ljubljana

Target Recruit Count: 23

Registration Number: NCT02352259

Locations: 🇸🇮
Faculty of Electrical Engineering, University of Ljubljana, Slovenia, Ljubljana, Slovenia
🇸🇮
Institute of Oncology Ljubljana, Ljubljana, Slovenia
🇸🇮
University Medical Centre Ljubljana, Ljubljana, Slovenia, Ljubljana, Slovenia

and more 1 locations

IMRT-SIB and Capecitabine in Preoperative Rectal Cancer Treatment

Phase 2

Conditions: Rectal Carcinoma

Interventions: Radiation: IMRT-SIB
Drug: Capecitabine
Procedure: Surgery

First Posted Date: 2014-10-20

Last Posted Date: 2014-10-20

Lead Sponsor: Institute of Oncology Ljubljana

Target Recruit Count: 50

Registration Number: NCT02268006

Locations: 🇸🇮
Institute of Oncology, Ljubljana, Slovenia

Effect of Concomitant Radiotherapy and Trastuzumab on Cardiotoxicity of Patients Treated for Early Breast Cancer

Completed

Conditions: Breast Cancer

First Posted Date: 2012-04-06

Last Posted Date: 2014-10-16

Lead Sponsor: Institute of Oncology Ljubljana

Target Recruit Count: 175

Registration Number: NCT01572883

Locations: 🇸🇮
Institut of oncology Ljubljana, Ljubljana, Slovenia

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy